![Teva Presents Data on SD-809 For the Treatment of Chorea in Huntington Disease - Huntington's Disease News Teva Presents Data on SD-809 For the Treatment of Chorea in Huntington Disease - Huntington's Disease News](https://huntingtonsdiseasenews.com/wp-content/uploads/2015/07/shutterstock_251684002.jpg)
Teva Presents Data on SD-809 For the Treatment of Chorea in Huntington Disease - Huntington's Disease News
![Hungry for brand sales, Teva undercuts generics with new, $60K Huntington's med Austedo | Fierce Pharma Hungry for brand sales, Teva undercuts generics with new, $60K Huntington's med Austedo | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-11/Teva.jpg?VersionId=t3f25umnzkncwqrMGLPFerqzWw3f4Eef)
Hungry for brand sales, Teva undercuts generics with new, $60K Huntington's med Austedo | Fierce Pharma
![Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease](https://orangecounty.hdsa.org/upload/tevaneuro-809551492541210.jpg)
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease
![Scientists identify precisely how pridopidine works in models of Huntington's disease - HDBuzz - Huntington's disease research news. Scientists identify precisely how pridopidine works in models of Huntington's disease - HDBuzz - Huntington's disease research news.](https://en.hdbuzz.net/system/production/media/picture/768/redesignarticle_codev-2021-06-12-dd82f1ce61-pridopidine_trials.jpg)
Scientists identify precisely how pridopidine works in models of Huntington's disease - HDBuzz - Huntington's disease research news.
Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (HD) Information, Inspiration and Resources on HD Chorea
![Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease | Business Wire Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease | Business Wire](https://mms.businesswire.com/media/20221018005197/en/739014/23/teva_RGB_JPEG.jpg)
Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease | Business Wire
![Teva data indicates long-term benefit of Austedo for chorea associated with Huntington's | Seeking Alpha Teva data indicates long-term benefit of Austedo for chorea associated with Huntington's | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1325883081/image_1325883081.jpg?io=getty-c-w750)
Teva data indicates long-term benefit of Austedo for chorea associated with Huntington's | Seeking Alpha
![Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities - The Lancet Neurology Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities - The Lancet Neurology](https://www.thelancet.com/cms/attachment/c10d80a2-81b5-4c76-bdfa-385e5ebb3703/gr1_lrg.jpg)
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities - The Lancet Neurology
![Huntington's drug sprung from Teva's lab moves forward with $62.5M VC backing | S&P Global Market Intelligence Huntington's drug sprung from Teva's lab moves forward with $62.5M VC backing | S&P Global Market Intelligence](https://www.snl.com/articles/404445275.png)